News Item

  • July 27, 2017

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced the appointment of Scott Armstrong, M.D, Ph.D., and Ross Levine, MD, to the Company’s...

News Item

  • March 23, 2017

CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif. –  C4 Therapeutics (C4T) and Calico today announced a five-year collaboration to discover, develop and commercialize...

News Item

  • November 17, 2016

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced Ken Anderson, M.D., Nathanael Gray, Ph. D., Christopher Kirk, Ph. D. and Eric Fischer,...

News Item

  • September 22, 2016

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced that Andrea Armstrong has been promoted to Chief Administrative Officer. She joined C4T as a human resources…

News Item

  • September 19, 2016

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced that it has been named by FierceBiotech as one of 2016’s Fierce 15 biotechnology companies, designating it…

News Item

  • September 14, 2016

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been promoted to President and Chief Scientific Officer, reporting directly to Executive…

News Item

  • September 2, 2016

Cambridge, Mass.- C4 Therapeutics (C4T) today announced details of the leadership team recruited to develop a new class of broadly applicable small molecule drugs for…

News Item

  • February 2, 2016

San Francisco, CA. -Fresh from announcing the creation of the company, a USD 75 million series A financing, and a deal with Roche which has…

News Item

  • February 2, 2016

Cambridge, MA. - C4 Therapeutics today announced the appointment of Andrew Phillips, Ph.D. as Chief Scientific Officer. Dr. Phillips joins from the Broad Institute of…

News Item

  • January 7, 2016

Cambridge, MA. - When physician-scientist Jay Bradner left the Dana-Farber Cancer Institute last year, he left behind some key scientific work that had already intrigued…